| Date | Company | Compound | Disease | Type of agreement | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2016-04-25 | Biomnis (France) Onco Drug Personalized Medicine (France) | pharmacogenetics tests (5-FUODPM Tox ™, 5-FUODPM Protocol ™) | collaboration |
Cancer - Oncology - Diagnostic | Collaboration agreement | |
| 2016-04-25 | Txcell (France) Ospedale San Raffaele (Italy) | CAR-Treg cellular therapy product | lupus nephritis | R&D |
Autoimmune diseases - Kidney diseases - Renal diseases | R&D agreement |
| 2016-04-25 | Epizyme (USA - MA) | nomination |
Cancer - Oncology | Nomination | ||
| 2016-04-25 | Opko Health (USA - Fl) | nomination |
Nomination | |||
| 2016-04-25 | Valeant Pharmaceuticals (Canada) | nomination |
Nomination | |||
| 2016-04-22 | Adaptimmune Therapeutics (UK) | nomination |
Cancer - Oncology | Nomination | ||
| 2016-04-22 | AstraZeneca (UK) Human Longevity (USA) the Wellcome Trust Sanger Institute (UK) The Institute for Molecular Medicine (Finland) | research - R&D - collaboration | Research agreement | |||
| 2016-04-21 | Ablynx (Belgium) Boehringer Ingelheim (Germany) | Nanobody® therapeutics | oncology, immunology, and respiratory diseases |
R&D |
Cancer Oncology - Immune diseases - Respiratory diseases | Milestone |
| 2016-04-21 | Novo Nordisk (Denmark) | Novo Nordisk's facilities in Chartres | diabetes | construction of new premises |
Metabolic diseases | Construction of new premises |
| 2016-04-21 | Opko Health (USA - Fl) | construction of new premises |
Construction of new premises | |||
| 2016-04-19 | Genmab (Denmark) IDD Biotech (France) | anti DR5 antibodies | product acquisition |
Cancer - Oncology | Milestone | |
| 2016-04-19 | Domainex (UK) Johnson Matthey (UK) | integrated small molecule pharmaceutical discovery and development services | collaboration |
Technology - Services | Collaboration agreement | |
| 2016-04-19 | MRC Technology (UK) | opening of new premises |
Opening of new premises | |||
| 2016-04-19 | Pierre Fabre laboratories (France) Evotec (Germany) | compound collection | collaboration |
Technology - Services | Collaboration agreement | |
| 2016-04-19 | Sanofi (France) | production site in Geel (Belgium) | construction of new premises |
Construction of new premises | ||
| 2016-04-19 | Anagenesis Biotechnologies (France) | Anagenesis Biotherapies Inc | establishment of a new subsidiary in the US |
Rare diseases - Genetic diseases - Neuromuscular diseases | Establishment of a new subsidiary in the US | |
| 2016-04-19 | ProBioGen (Germany) Eucodis Bioscience (Austria) | C-LiNK (CTAT) | licensing |
Technology - Services | Licensing agreement | |
| 2016-04-19 | Astex Pharmaceuticals (UK) Genentech, a member of Roche Group (USA - CA - Switzerland) | guadecitabine and atezolizumab | acute myeloid leukemia | clinical research |
Cancer - Oncology | Clinical research agreement |
| 2016-04-19 | Melinta Therapeutics (USA - CT) | nomination | Infectious diseases | Nomination | ||
| 2016-04-19 | Synpromics (UK) | member of the board of directors | nomination | Technology - Services | Nomination |
